Andrea De Vito

Prof. Andrea De Vito

Health Local Agency of Romagna, Ravenna, Emilia-Romagna, Italy
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2020 in Head & Neck
Verified
Journal Article
Closed access
PDF file
Luigi Angelo VairaLuigi Angelo Vaira
Luigi Angelo Vaira
GDGiovanna Deiana
Giovanna Deiana
AFAlessandro Giuseppe Fois
Alessandro Giuseppe Fois
PPPietro Pirina
Pietro Pirina
Giordano MadedduGiordano Madeddu
Giordano Madeddu
GRGiacomo De Riu
Giacomo De Riu

26 May 2014 in Sleep and Breathing
Verified
Journal Article
Closed access
PDF file
Andrea De VitoAndrea De Vito
Andrea De Vito
MLMarina Carrasco Llatas
Marina Carrasco Llatas
AVAgnoletti Vanni
Agnoletti Vanni
MBMarcello Bosi
Marcello Bosi
ABAlberto Braghiroli
Alberto Braghiroli
CVClaudio Vicini
Claudio Vicini

22 August 2018 in Clinical Otolaryngology
Verified
Journal Article
Closed access
PDF file
Andrea De VitoAndrea De Vito
Andrea De Vito
MCMarina Carrasco-Llatas
Marina Carrasco-Llatas
MRMadeline J. Ravesloot
Madeline J. Ravesloot
BKBhik Kotecha
Bhik Kotecha
NVNico De Vries
Nico De Vries
CVClaudio Vicini
Claudio Vicini

21 May 2020 in Head & Neck
Verified
Journal Article
Closed access
PDF file
Luigi Angelo VairaLuigi Angelo Vaira
Luigi Angelo Vaira
CHClaire Hopkins
Claire Hopkins
GSGiovanni Salzano
Giovanni Salzano
MPMarzia Petrocelli
Marzia Petrocelli
AMAndrea Melis
Andrea Melis
GRGiacomo De Riu
Giacomo De Riu

GGGiampiero Gulotta
Giampiero Gulotta
GIGIANNICOLA IANNELLA
GIANNICOLA IANNELLA
CVClaudio Vicini
Claudio Vicini
Antonella PolimeniAntonella Polimeni
Antonella Polimeni
Antonio GrecoAntonio Greco
Antonio Greco
Giuseppe MagliuloGiuseppe Magliulo
Giuseppe Magliulo
The obstructive sleep apnea syndrome (OSAS) represents only part of a large group of pathologies of variable entity called respiratory sleep disorders (RSD) which include simple snoring and increased upper airway resistance syndrome (UARS). Although the etiopathogenesis of adult OSAS is well known, many aspects of this syndrome in children are still debated. Its prevalence is about 2% in children from 2 to 8 years of age, mostly related to the size of the upper airways adenoid tissue. Several risk factors linked to the development of OSAS are typical of the pediatric age. The object of this paper is to analyze the state of the art on this specific topic, discussing its implications in terms of diagnosis and management.

13 January 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Antonino ManiaciAntonino Maniaci
Antonino Maniaci
GIGiannicola Iannella
Giannicola Iannella
Salvatore CocuzzaSalvatore Cocuzza
Salvatore Cocuzza
CVClaudio Vicini
Claudio Vicini
Giuseppe MagliuloGiuseppe Magliulo
Giuseppe Magliulo
STSamanta Taurone
Samanta Taurone
Obstructive Sleep Apnea Syndrome (OSAS) is a respiratory sleep disorder characterised by repeated episodes of partial or complete obstruction of the upper airway during the night. This obstruction usually occurs with a reduction (hypopnea) or complete cessation (apnea) of the airflow in the upper airways with the persistence of thoracic-diaphragmatic respiratory movements. During the hypopnea/apnea events, poor alveolar ventilation reduces the oxygen saturation in the arterial blood (SaO2) and a gradual increase in the partial arterial pressure of carbon dioxide (PaCO2). The direct consequence of the intermittent hypoxia is an oxidative imbalance, with reactive oxygen species production and the inflammatory cascade’s activation with pro and anti-inflammatory cytokines growth. Tumour necrosis factors, inflammatory cytokines (IL2, IL4, IL6), lipid peroxidation, and cell-free DNA have been found to increase in OSAS patients. However, even though different risk-related markers have been described and analysed in the literature, it has not yet been clarified whether specified inflammatory bio-markers better correlates with OSAS diagnosis and its clinical evolution/comorbidities. We perform a scientific literature review to discuss inflammatory and oxidative stress biomarkers currently tested in OSAS patients and their correlation with the disease’s severity and treatment.